|WHEN||November 03, 2012 @ 8:00am - 5:00pm|
|When:8:30 am – 4:00 pm, Saturday, November 3rd, 2012Where:Institute of Americas, UCSD
$20 online by Sep. 26; $10 for students and post-docs. $40 onsite.
Registration fee includes parking, program brochure, breakfast, coffee, and lunch.
Advances in Diagnostics for Improved Patient Care
The global IVD market was valued at $44 billion in the year 2011, growing at a CAGR of 7.8% from 2011 to 2016. Advancements in molecular technology, personalized medicine, point of care testing and a competitive landscape are the major drivers improving clinical decisions contributing to improved patient care. This forum offers a comprehensive view of the innovations and challenges of the diagnostics industry and a platform of opportunity to interact with leaders in this field. Come hear from key players from industry and academics share their experience and vision on next generation sequencing, CLIA testing, proteomics, marketing & sales strategy, IP issues related with gene testing and contract development and manufacturing.
9:00 Opening Remarks
9:15 Keynote:Dr. Paul Billings, , M.D. Ph.D.Repersonalizing MecicineCMO, Life Technologies
9:45 Jonathan Diver, Ph.D. The Business of InVitro Diagnostics: Regulations, CLIA Operations, andFinancial Complications Senior VP of Lab Operations, Genoptix, a Novartis Company
10:15 Coffee Break
10:30 Peter Simpson, Building a Platform for Success: Leading Glucose Sensor Technologies forDiagnostic and Therapeutic Applications Senior Director of R&D, Dexcom
11:00 Heather Devereaux, Information Trends Driving Device and Diagnostic Breakthroughs,Customer Engagement Team Manager, Elsevier
11:15 Andrew Wang,Nanoparticles for Biomedical Device and Diagnostics,President, Ocean NanoTech
11:30 David K. Stelter, Think Global – Act Local,VP of Business Development, BIT MedTech,President, Ocean NanoTech
1:30 Bing Ren, Ph.D. Epigenetic Signatures of Cell StatesProfessor, Department of Cellular and Molecular Medicine, UCSD
2:00 Peng Chen, Ph.D. America Invents Act Challenges and OpportunitiesPartner, Morrison & Foerster
2:30 Panel Discussion: A New Paragdigm in the Contract Manufacturing of Diagnostic Devices andEmerging Point of Care Technologies
Moderator:Caroline Cheung, President, Allied Intrade
Panelists:Brian Kelleher, Managing Partner, Tigris Ventures
Alex Kunczynski, President, D&K Engineering
Michelle Lum, Deputy General Manager, Automatic Manufacturing Limited
Junquan Xu, COO, CapitalBio
3:30 Closing Remarks